{"schema_version":"secwatch.filing_event.v1","accession":"0000200406-26-000167","form_type":"8-K","ticker":"JNJ","cik":"0000200406","company_name":"JOHNSON & JOHNSON","filed_at":"2026-08-04T12:48:52+00:00","discovered_at":"2026-08-04T12:50:00.552556+00:00","generated_at":"2026-08-04T12:50:07.780131+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Jennifer Taubert, EVP and Worldwide Chairman of Innovative Medicine, to retire Sept 1, 2026","bullets":["Jennifer Taubert retiring as EVP, Worldwide Chairman of Innovative Medicine and member of Executive Committee.","Retirement effective September 1, 2026.","No successor has been named at this time.","Announcement made on August 4, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000200406-26-000167","json":"https://secwatch.observer/filing/0000200406-26-000167.json","markdown":"https://secwatch.observer/filing/0000200406-26-000167.md","text":"https://secwatch.observer/filing/0000200406-26-000167.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000167/0000200406-26-000167-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000167/jnj-20260804.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T12:50:07.780131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}